- 期刊
Polymethoxyflavones as Food Factors for the Management of Inflammatory Diseases
並列摘要
Recent researches have expanded the concept that inflammation is a critical component of human diseases. The possible mechanisms by which inflammation contribute to various conditions include increase of reactive species and inflammatory cytokines and growth factors leading to alteration of biomolecules, induction of genetic change, cellular dysfunction and enhancement of transformation or proliferation. Thus, targeting the inflammation is potential strategy for prevention of chronic diseases. Numerous epidemiological and laboratory studies suggest that polymethoxyflavones (PMFs) exhibit a broad spectrum of biological activities. Recently, we isolated and identified hydroxylated PMFs from citrus peels and have investigated their biological activities, including anti-inflammation and cancer chemopreventive property. We suggest that hydroxylated PMFs possess greater biological activity potency for chemoprevention on targeting inflammation.
延伸閱讀
- 曾屏輝（2014）。Clinical Implication and Pathophysiology of Metabolic Factors in Gastrointestinal Disease〔博士論文，國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2014.10064
- Hirai, S., Takahashi, N., Goto, T., Lin, S., Uemura, T., Yu, R., & Kawada, T. (2010). Functional Food Targeting the Regulation of Obesity-Induced Inflammatory Responses and Pathologies. Mediators of Inflammation, 2010(), 382-389. https://doi.org/10.1155/2010/367838
- 洪瑋靖、陳怡儒、陳冠妤、張美華、廖家鼎、高雅敏、王德原、陳惠芳（2018）。Determination of Polycyclic Aromatic Hydrocarbons in Foods。食品藥物研究年報，(9)，25-38。https://www.airitilibrary.com/Article/Detail?DocID=22195718-201812-201901110010-201901110010-25-38
- Schifilliti, C., Cucinotta, L., Fedele, V., Ingegnosi, C., Luca, S., & Leotta, C. (2014). Micronized Palmitoylethanolamide Reduces the Symptoms of Neuropathic Pain in Diabetic Patients. Pain Research and Treatment, (2014), 175-179. https://doi.org/10.1155/2014/849623
- Delporte, C., Antwerpen, P. V., Vanhamme, L., Roumeguère, T., & Boudjeltia, K. Z. (2013). Low-Density Lipoprotein Modified by Myeloperoxidase in Inflammatory Pathways and Clinical Studies. Mediators of Inflammation, 2013(), 569-586. https://doi.org/10.1155/2013/971579